Copper(II) Can Kinetically Trap Arctic and Italian Amyloid-β40 as Toxic Oligomers, Mimicking Cu(II) Binding to Wild-Type Amyloid-β42: Implications for Familial Alzheimer's Disease
- PMID: 38425915
- PMCID: PMC10900208
- DOI: 10.1021/jacsau.3c00687
Copper(II) Can Kinetically Trap Arctic and Italian Amyloid-β40 as Toxic Oligomers, Mimicking Cu(II) Binding to Wild-Type Amyloid-β42: Implications for Familial Alzheimer's Disease
Abstract
The self-association of amyloid-β (Aβ) peptide into neurotoxic oligomers is believed to be central to Alzheimer's disease (AD). Copper is known to impact Aβ assembly, while disrupted copper homeostasis impacts phenotype in Alzheimer's models. Here we show the presence of substoichiometric Cu(II) has very different impacts on the assembly of Aβ40 and Aβ42 isoforms. Globally fitting microscopic rate constants for fibril assembly indicates copper will accelerate fibril formation of Aβ40 by increasing primary nucleation, while seeding experiments confirm that elongation and secondary nucleation rates are unaffected by Cu(II). In marked contrast, Cu(II) traps Aβ42 as prefibrillar oligomers and curvilinear protofibrils. Remarkably, the Cu(II) addition to preformed Aβ42 fibrils causes the disassembly of fibrils back to protofibrils and oligomers. The very different behaviors of the two Aβ isoforms are centered around differences in their fibril structures, as highlighted by studies of C-terminally amidated Aβ42. Arctic and Italian familiar mutations also support a key role for fibril structure in the interplay of Cu(II) with Aβ40/42 isoforms. The Cu(II) dependent switch in behavior between nonpathogenic Aβ40 wild-type and Aβ40 Arctic or Italian mutants suggests heightened neurotoxicity may be linked to the impact of physiological Cu(II), which traps these familial mutants as oligomers and curvilinear protofibrils, which cause membrane permeability and Ca(II) cellular influx.
© 2024 The Authors. Published by American Chemical Society.
Conflict of interest statement
The authors declare no competing financial interest.
Figures









Similar articles
-
Cross-seeding of WT amyloid-β with Arctic but not Italian familial mutants accelerates fibril formation in Alzheimer's disease.J Biol Chem. 2022 Jul;298(7):102071. doi: 10.1016/j.jbc.2022.102071. Epub 2022 May 25. J Biol Chem. 2022. PMID: 35643314 Free PMC article.
-
Structural Polymorphism of Alzheimer's β-Amyloid Fibrils as Controlled by an E22 Switch: A Solid-State NMR Study.J Am Chem Soc. 2016 Aug 10;138(31):9840-52. doi: 10.1021/jacs.6b03715. Epub 2016 Jul 28. J Am Chem Soc. 2016. PMID: 27414264 Free PMC article.
-
The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.FEBS J. 2014 Jun;281(11):2674-87. doi: 10.1111/febs.12813. Epub 2014 May 6. FEBS J. 2014. PMID: 24720730
-
Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease.Acta Biochim Pol. 2005;52(2):417-23. Epub 2005 May 31. Acta Biochim Pol. 2005. PMID: 15933761 Review.
-
Effects of Cu(II) on the aggregation of amyloid-β.J Biol Inorg Chem. 2019 Dec;24(8):1197-1215. doi: 10.1007/s00775-019-01727-5. Epub 2019 Oct 10. J Biol Inorg Chem. 2019. PMID: 31602542 Review.
Cited by
-
Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.Signal Transduct Target Ther. 2025 Feb 3;10(1):31. doi: 10.1038/s41392-024-02071-0. Signal Transduct Target Ther. 2025. PMID: 39894843 Free PMC article. Review.
-
Pharmacological effects, molecular mechanisms and strategies to improve bioavailability of curcumin in the treatment of neurodegenerative diseases.Front Pharmacol. 2025 Jul 10;16:1625821. doi: 10.3389/fphar.2025.1625821. eCollection 2025. Front Pharmacol. 2025. PMID: 40709087 Free PMC article. Review.
-
Cell-specific copper dyshomeostasis mechanism in Alzheimer's disease.Transl Neurodegener. 2025 Aug 22;14(1):42. doi: 10.1186/s40035-025-00504-6. Transl Neurodegener. 2025. PMID: 40847318 Free PMC article. Review.
-
Identifying the copper coordination environment between interacting neurodegenerative proteins: A new approach using pulsed EPR with 14N/15N isotopic labeling.J Biol Chem. 2025 Mar;301(3):108311. doi: 10.1016/j.jbc.2025.108311. Epub 2025 Feb 13. J Biol Chem. 2025. PMID: 39955064 Free PMC article.
References
-
- Naslund J.; Schierhorn A.; Hellman U.; Lannfelt L.; Roses A. D.; Tjernberg L. O.; Silberring J.; Gandy S. E.; Winblad B.; Greengard P.; et al. Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. Proc. Natl. Acad. Sci. U.S.A. 1994, 91 (18), 8378–8382. 10.1073/pnas.91.18.8378. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources